Jul 27, 2026
Mark Larkin, Founder and CEO of Vitaccess, leverages real-world patient data captured through mobile devices and wearables, combined with EMRs, claims data, and registries, to generate insights beyond the scope of traditional clinical trials. The company maintains proprietary disease registries, notably in myasthenia...
Microwave Ablation Provides Minimally Invasive Treatment Option for Benign Thyroid Nodules with Mark Saxton Baird Medical TRANSCRIPT
Download PDFJul 20, 2026
Mark Saxton, CEO of Baird Medical, highlights their microwave ablation technology, which is being used to address a significant treatment gap for benign thyroid nodules. This minimally invasive approach is an alternative to radiofrequency ablation, accommodates patients with pacemakers or other cardiac devices, and...
Jul 20, 2026
Mark Saxton, CEO of Baird Medical, highlights their microwave ablation technology, which is being used to address a significant treatment gap for benign thyroid nodules. This minimally invasive approach is an alternative to radiofrequency ablation, accommodates patients with pacemakers or other cardiac devices, and...
Open-Source Focused Ultrasound and Infrared MedTech to Advance Stroke Diagnosis and Neurological Therapies Aaron Timm Openwater TRANSCRIPT
Download PDFJul 16, 2026
Aaron Timm, CEO of Openwater, is driving the shift from single-purpose, room-sized equipment to multi-purpose, portable, light-weight medical devices designed on an open-source platform. Some tools use infrared light to measure blood flow in real time for applications such as stroke detection. Another device...
Jul 16, 2026
Aaron Timm, CEO of Openwater, is driving the shift from single-purpose, room-sized equipment to multi-purpose, portable, light-weight medical devices designed on an open-source platform. Some tools use infrared light to measure blood flow in real time for applications such as stroke detection. Another device...